Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus

Journal of Immunology

Volumn 173, Issue 6, 2004, Pages 3925-3934

  Basler, Michael ^a   Youhnovski, Nikolay ^a   Van Den Broek, Maries ^b   Przybylski, Michael ^a   Groettrup, Marcus ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; PROTEASOME;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; IMMUNOREACTIVITY; INTERFERON PRODUCTION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 4644249095     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.6.3925     Document Type: Article

References (49)

1. Deng, Y., J. W. Yewdell, L. C. Eisenlohr, and J. R. Bennink. 1997. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J. Immunol. 158:1507.
2. Gallimore, A., J. Hombach, T. Dumrese, H. G. Rammensee, R. M. Zinkernagel, and H. Hengartner. 1998. A protective cytotoxic T cell response to a subdominant epitope is influenced by the stability of the MHC class I/peptide complex and the overall spectrum of viral peptides generated within infected cells. Eur. J. Immunol. 28:3301.
3. Chen, W., L. C. Anton, J. R. Bennink, and J. W. Yewdell. 2000. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity 12:83.
4. Yewdell, J. T., and J. R. Bennink. 1999. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 17:51.
5. Townsend, A., J. Bastin, K. Gould, G. Brownlee, M. Andrew, B. Coupar, D. Boyle, S. Chan, and G. Smith. 1988. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J. Exp. Med. 168:1211.
6. Rammensee, H. G., J. Bachmann, N. P. N. Emmerich, O. A. Bachor, and S. Stevanovic. 1999. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50:213.
7. Lanzavecchia, A., G. Iezzi, and A. Viola. 1999. From TCR engagement to T cell activation: a kinetic view of T cell behavior. Cell 96:1.
8. + T cells during negative selection results in an altered antiviral T cell hierarchy. J. Immunol. 170:1231.
9. Van der Most, R. G., A. Sette, C. Oseroff, J. Alexander, K. Murali-Krishna, L. L. Lau, S. Southwood, J. Sidney, R. W. Chestnut, M. Matloubian, and R. Ahmed. 1996. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. J. Immunol. 157:5543.
10. Van der Most, R. G., K. MuraliKrishna, J. L. Whitton, C. Oseroff, J. Alexander, S. Southwood, J. Sidney, R. W. Chesnut, A. Sette, and R. Ahmed. 1998. Identification of D-b- and K-b-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice. Virology 240:158.
11. Gallimore, A., T. Dumrese, H. Hengartner, R. M. Zinkernagel, and H.-G. Rammensee. 1998. Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides. J. Exp. Med. 187:1647.
12. + T cell epitopes, virus load, and kinetics of primary antiviral CTL response. J. Immunol. 160:2923.
13. Christinck, E. R., M. A. Luscher, B. H. Barber, and D. B. Williams. 1991. Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature 352:67.
14. Kageyama, S., T. J. Tsomides, Y. Sykulev, and H. N. Eisen. 1995. Variations in the number of peptide-MHC class I complexes required to activate cytotoxic T cell responses. J. Immunol. 154:567.
15. Schwarz, K., R. de Giuli, G. Schmidtke, S. Kostka, M. van den Broek, K. Kim, C. M. Crews, R. Kraft, and M. Groettrup. 2000. The selective proteasome inhibitors lactacystin and expoxomicin can be used to either up- or down-regulate antigen presentation at non-toxic doses. J. Immunol. 164:6147.
16. Groettrup, M., A. Soza, U. Kuckelkorn, and P. M. Kloetzel. 1996. Peptide antigen production by the proteasome: complexity provides efficiency. Immunol. Today 17:429.
17. Voges, D., P. Zwickl, and W. Baumeister. 1999. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem. 68:1015.
18. Gileadi, U., H. T. MoinsTeisserenc, I. Correa, B. L. Booth, P. R. Dunbar, A. K. Sewell, J. Trowsdale, R. E. Phillips, and V. Cerundolo. 1999. Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein. J. Immunol. 163:6045.
19. Schwarz, K., M. van den Broek, S. Kostka, R. Kraft, A. Soza, G. Schmidtke, P. M. Kloetzel, and M. Groettrup. 2000. Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1 but not PA28α/β enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope. J. Immunol. 165:768.
20. Sijts, A. J. A. M., S. Standera, R. E. M. Toes, T. Ruppert, N. J. C. M. Beekman, P. A. vanVeelen, F. A. Ossendorp, C. J. M. Melief, and P. M. Kloetzel. 2000. MHC class I antigen processing of an adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells. J. Immunol. 164:4500.
21. Schultz, E. S., J. Chapiro, C. Lurquin, S. Claverol, O. BurletSchiltz, G. Warnier, V. Russo, S. Morel, F. Levy, T. Boon, et al. 2002. The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome. J. Exp. Med. 195:391.
22. Morel, S., F. Levy, O. BurletSchiltz, F. Brasseur, M. ProbstKepper, A. L. Peitrequin, B. Monsarrat, R. VanVelthoven, J. C. Cerottini, T. Boon, et al. 2000. Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells. Immunity 12:107.
23. Van Kaer, L., P. G. Ashton-Rickardt, M. Eichelberger, M. Gaczynska, K. Nagashima, K. L. Rock, A. L. Goldberg, P. C. Doherty, and S. Tonegawa. 1994. Altered peptidase and viral-specific T cell response in LMP 2 mutant mice. Immunity 1:533.
24. Fehling, H. J., W. Swat, C. Laplace, R. Kuehn, K. Rajewsky, U. Mueller, and H. von Boehmer. 1994. MHC class I expression in mice lacking proteasome subunit LMP-7. Science 265:1234.
25. + T cells at the levels of T cell repertoire and presentation of viral antigens. J. Exp. Med. 193:1319.
26. Dubiel, W., G. Pratt, K. Ferrell, and M. Rechsteiner. 1992. Purification of an 11S regulator of the multicatalytic proteinase. J. Biol. Chem. 267:22369.
27. Chu-Ping, M., C. A. Slaughter, and G. N. DeMartino. 1992. Identification, purification and characterization of a protein activator (PA28) of the 20S proteasome (macropain). J. Biol. Chem. 267:10515.
28. Groettrup, M., T. Ruppert, L. Kuehn, M. Seeger, S. Standera, U. Koszinowski, and P. M. Kloetzel. 1995. The interferon-γ-inducible 11S regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20S proteasome in vitro. J. Biol. Chem. 270:23808.
29. Groettrup, M., A. Soza, M. Eggers, L. Kuehn, T. P. Dick, H. Schild, H.-G. Rammensee, U. H. Koszinowski, and P.-M. Kloetzel. 1996. A role for the proteasome regulator PA28α in antigen presentation. Nature 381:166.
30. Schwarz, K., M. Eggers, A. Soza, U. H. Koszinowski, P. M. Kloetzel, and M. Groettrup. 2000. The proteasome regulator PA28α/β can enhance antigen presentation without affecting 20S proteasome subunit composition. Eur. J. Immunol. 30:3672.
31. Van Hall, T., A. Sijts, M. Camps, R. Offringa, C. Melief, P. M. Kloetzel, and F. Ossendorp. 2000. Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28. J. Exp. Med 192:483.
32. Yamano, T., S. Murata, N. Shimbara, N. Tanaka, T. Chiba, K. Tanaka, K. Yui, and H. Udono. 2002. Two distinct pathways mediated by PA28 and hsp90 in major histocompatibility complex class I antigen processing. J. Exp. Med. 196:185.
33. -/- mice. Science 286:2162.
34. Murata, S., H. Udono, N. Tanahashi, N. Hamada, K. Watanabe, K. Adachi, T. Yamano, K. Yui, N. Kobayashi, M. Kasahara, et al. 2001. Immunoproteasome assembly and antigen presentation in mice lacking both PA28α and PA28β. EMBO J. 20:5898.
35. Aden, D. P., and B. B. Knowles. 1976. Cell surface antigens coded for by the human chromosome 7. Immunogenetics 3:209.
36. Bruns, M., J. Cihak, G. Müller, and F. Lehmann-Grube. 1983. Lymphocytic choriomeningitis virus. VI. Isolation of a glycoprotein mediating neutralization. Virology 130:247.
37. Schwarz, K., M. van den Broek, R. de Giuli, W. W. Seelentag, N. Shastri, and M. Groettrup. 2000. The use of LCMV-specific Tcell hybridomas for the quantitative analysis of MHC class I restricted antigen presentation. J. Immunol. Methods 237:199.
38. b-restricted cytotoxic T cells. Eur. J. Immunol. 20:523.
39. Khan, S., M. van den Broek, K. Schwarz, R. de Giuli, P. A. Diener, and M. Groettrup. 2001. Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver. J. Immunol. 167:6859.
40. Probst, H. C., K. Tschannen, A. Gallimore, M. Martinic, M. Basler, T. Dumrese, E. Jones, and M. F. van den Broek. 2003. Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression. J. Immunol. 171:5415.
41. Macagno, A., M. Gilliet, F. Sallusto, A. Lanzavecchia, F. O. Nestle, and M. Groettrup. 1999. Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturation. Eur. J. Immunol. 29:4037.
42. Macagno, A., L. Kuehn, R. de Giuli, and M. Groettrup. 2001. Pronounced up-regulation of the PA28α/β proteasome regulator but little increase in the steady state content of immunoproteasomes during dendritic cell maturation. Eur. J. Immunol. 31:3271.
43. + T-cell responses is dramatically modified by DNA immunization and is regulated by γ interferon. J. Virol. 76:4251.
44. Butz, E. A., and M. J. Bevan. 1998. Differential presentation of the same MHC class I epitopes by fibroblasts and dendritic cells. J. Immunol. 160:2139.
45. Groettrup, M., S. Standera, R. Stohwasser, and P. M. Kloetzel. 1997. The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome. Proc. Natl. Acad. Sci. USA 94:8970.
46. Griffin, T. A., D. Nandi, M. Cruz, H. J. Fehling, L. VanKaer, J. J. Monaco, and R. A. Colbert. 1998. Immunoproteasome assembly: cooperative incorporation of interferon γ (IFN-γ)-inducible subunits. J. Exp. Med. 187:97.
47. De, M., K. Jayarapu, L. Elenich, J. J. Monaco, R. A. Colbert, and T. A. Griffin. 2003. β2 subunit propeptides influence cooperative proteasome assembly. J. Biol. Chem. 278:6153.
48. Wherry, E. J., J. N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77:4911.
49. Fuller, M. J., and A. J. Zajac. 2003. Ablation of CD8 and CD4 T cell responses by high viral loads. J. Immunol. 170:477.